Storage conditions：Short-term storage at 2~8℃, long-term storage at -20 ~ -80℃
Hupehenine (CAS number: 98243-57-3) is a nonsteroidal alkaloid derived from the traditional Chinese medicine Fritillaria hupehensis. In recent years, it has received widespread attention for its diverse pharmacological activities. As an orally effective natural product, huperzine not only has traditional cough suppressant and expectorant effects, but also exhibits significant anti-cancer, antiparasitic, and neuroprotective activities, especially in the research of neurodegenerative diseases such as Parkinson's disease, showing unique potential. This article provides a systematic review of the chemical structure and physicochemical properties, plant sources and extraction methods, pharmacological activity and mechanism of action, pharmacological evaluation, pharmacokinetic characteristics, and clinical application prospects of huperzine, aiming to provide scientific basis for subsequent basic research and clinical development.
Hubeisu belongs to the class of steroid alkaloids, with a molecular formula of C27H43NO3 and a molecular weight of 415.6620. Its structure is based on a typical steroid skeleton, containing nitrogen atoms that give it alkaline characteristics. The LogP value of huperzine A is 4.2778, indicating high lipid solubility, which is beneficial for its penetration of cell membranes and the blood-brain barrier (BBB). Its topological polar surface area (TPSA) is 43.7 Å ², making it a moderately polar molecule with a certain degree of water solubility (0.0408 mg/mL) and good membrane permeability. It is worth noting that huperzine has high blood-brain barrier permeability, indicating its potential application in central nervous system diseases. In addition, huperzine does not exhibit hERG channel inhibitory activity, reducing the risk of cardiac toxicity, and the Ames mutagenicity test result is negative, indicating a low genetic toxicity risk.
Hubeisu is mainly isolated from Fritillaria hupehensis. Chuanbeimu is a perennial herbaceous plant belonging to the Liliaceae family, widely distributed in central and southwestern China. Its dried bulb is a traditional Chinese medicinal herb, which has always been used to treat cough, phlegm accumulation, and lung diseases.
Traditional extraction methods often use alcohol extraction combined with acid-base separation technology. The specific process includes:
In recent years, the introduction of ultrasound assisted extraction, microwave-assisted extraction, and membrane separation technologies has improved extraction efficiency and purity, and reduced process costs.
As an important active ingredient of traditional Chinese medicine Fritillaria thunbergii, huperzine plays a crucial role in relieving cough and eliminating phlegm. In vitro and in vivo experiments have shown that Hubeijia can effectively inhibit cough reflex, promote respiratory mucus secretion, dilute sputum, enhance ciliary movement, and promote sputum excretion. Its mechanism of action may be related to regulating airway smooth muscle tone and inhibiting the release of inflammatory mediators.
Hubeijia has shown inhibitory effects on various tumor cells, especially in liver cancer cell lines. In vitro experiments have shown that huperzine can induce apoptosis in liver cancer cells, inhibit cell proliferation and migration. Its anti-cancer effect involves multiple signaling pathways and molecular targets, including:
Hubeisu exhibits inhibitory effects on various parasites, especially on schistosomiasis and certain protozoa. Its anti parasitic mechanism may involve interference with parasite energy metabolism and cell membrane damage, and further in-depth research is needed.
The latest research has found that huperzine can inhibit alpha synuclein induced fiber formation, reduce the accumulation of neuronal toxicity, and suggest its potential application value in neurodegenerative diseases such as Parkinson's disease. Both in vitro cell models and animal experiments have confirmed its neuroprotective and anti-inflammatory effects on neurons.
The multi-target mechanism of action of huperzine A is the basis for its multiple pharmacological activities. Its main mechanism of action includes:
Regulating apoptosis and cell cycle
Hubeisu promotes mitochondrial mediated apoptosis by regulating the expression of BCL2 family proteins. At the same time, it affects the STAT3 and MAPK1 signaling pathways, blocks cell cycle progression, and inhibits tumor cell proliferation.
Inhibit tumor invasion and metastasis
By downregulating the matrix metalloproteinase MMP9, huperzine reduces the ability of tumor cells to degrade the matrix and inhibits tumor metastasis.
Anti inflammatory and immune regulation
Inhibit the expression of PTGS2 (COX-2), reduce the generation of pro-inflammatory mediators, regulate the tumor microenvironment and neuroinflammatory response.
Neuroprotective mechanism
Inhibiting abnormal aggregation of alpha synuclein, reducing neurotoxicity, protecting dopaminergic neurons, and delaying neurodegenerative processes.
Antiparasitic mechanism
May cause parasite death by interfering with parasite metabolic enzyme activity and membrane structure stability.
The synergistic effects of these multiple targets and pathways endow Hubeijia with extensive pharmacological activity and potential applications.
The pharmacological evaluation of Hubeijia Su shows that it has good potential for drug development:
In terms of pharmacokinetics, existing studies are mostly based on animal models, showing that huperzine is well absorbed after oral administration, with a moderate plasma half-life, mainly metabolized through the liver, and excreted through bile and urine pathways. Its high lipid solubility promotes its widespread distribution in tissues, especially in brain tissue. Further research on human pharmacokinetics is needed in the future to clarify its bioavailability, metabolic pathways, and drug interactions.
Hubeijia, as a multifunctional natural product, has a wide range of clinical application potential:
Respiratory system diseases
Its antitussive and expectorant effects make it suitable as an adjuvant therapy for chronic bronchitis, asthma, and pulmonary infections.
tumor therapy
By regulating tumor growth and metastasis through multiple targets, huperzine is expected to serve as an adjuvant or combination therapy for liver cancer and other solid tumors. Combining modern drug delivery systems, such as nanocarriers, is expected to improve their targeting and efficacy.
Neurodegenerative diseases
The ability to resist alpha synuclein aggregation provides new ideas for the treatment of diseases such as Parkinson's disease. In the future, preclinical and clinical studies can be conducted in combination with other neuroprotective drugs.
Antiparasitic therapy
In areas with high incidence of parasitic diseases, huperzine has promotional value as a natural antiparasitic drug.
Future research should focus on:
Hubeisu, as a type of nonsteroidal alkaloid derived from Fritillaria thunbergii, has shown broad research and application prospects due to its diverse pharmacological activities and good medicinal properties. Its potential in the fields of cough control, phlegm removal, anti-cancer, anti parasitic, and neuroprotection is particularly noteworthy in the treatment research of liver cancer and Parkinson's disease. In the future, through in-depth mechanism research, optimization of formulation technology, and clinical validation, Hubeijia is expected to become an important representative of natural product drug development, contributing new treatment options to human health.
